FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966335217> ?p ?o ?g. }

• W1966335217 endingPage "845" @default.
• W1966335217 startingPage "840" @default.
• W1966335217 abstract "Background Imatinib mesylate, a tyrosine kinase inhibitor, is used in the treatment of chronic myelogeneous leukemia (CML). Given its ease of administration and manageable side effects in adults, imatinib mesylate was introduced as therapy for pediatric CML. Recently published case reports describe growth deceleration in children treated with imatinib. This study details the growth phenotype of seven pediatric patients maintained in remission on imatnib mesylate over an extended period of time. Procedure This study is a retrospective chart review of pediatric patients with CML at Oregon Health & Science University treated with imatinib. Height, weight, and body mass index (BMI) measurements were collected before and during treatment. Median standard deviation scores (SDS) were analyzed by Wilcoxon Rank-Sum test and Wilcoxon signed rank cohort analysis. Results Individual patient analysis demonstrated five of seven subjects with a statistically significant decrease in height SDS pre versus during treatment. The whole group analysis showed a trend to significance for difference in median height SDS pre and during treatment (P = 0.078). Bone age was delayed in all four patients in whom bone ages were obtained. IGF-1, IGFBP-3, and thyroid levels during treatment were normal. Four patients experienced an improvement in height SDS during puberty. However, three patients approaching near final adult height failed to achieve genetic height potential determined by mid-parental target height. Conclusion Growth in children with CML appears to be adversely impacted by imatinib therapy. BMI and IGF-1/IGFBP-3 are maintained during treatment, suggesting a direct effect of imatinib on the growth plate. Pediatr Blood Cancer 2012; 59: 840–845. © 2012 Wiley Periodicals, Inc." @default.
• W1966335217 created "2016-06-24" @default.
• W1966335217 creator A5016103334 @default.
• W1966335217 creator A5024930133 @default.
• W1966335217 creator A5032442321 @default.
• W1966335217 creator A5045437866 @default.
• W1966335217 creator A5070781431 @default.
• W1966335217 creator A5091260162 @default.
• W1966335217 date "2012-02-29" @default.
• W1966335217 modified "2023-09-27" @default.
• W1966335217 title "Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia" @default.
• W1966335217 cites W1551536291 @default.
• W1966335217 cites W1967934593 @default.
• W1966335217 cites W1970595617 @default.
• W1966335217 cites W1972059947 @default.
• W1966335217 cites W1973944171 @default.
• W1966335217 cites W2010227622 @default.
• W1966335217 cites W2015846334 @default.
• W1966335217 cites W2018792615 @default.
• W1966335217 cites W2027567560 @default.
• W1966335217 cites W2032569611 @default.
• W1966335217 cites W2053566054 @default.
• W1966335217 cites W2064704460 @default.
• W1966335217 cites W2083227753 @default.
• W1966335217 cites W2084452268 @default.
• W1966335217 cites W2090663991 @default.
• W1966335217 cites W2091735622 @default.
• W1966335217 cites W2091998318 @default.
• W1966335217 cites W2107419121 @default.
• W1966335217 cites W2114627676 @default.
• W1966335217 cites W2133876644 @default.
• W1966335217 cites W2147102614 @default.
• W1966335217 cites W2149753558 @default.
• W1966335217 cites W2171722798 @default.
• W1966335217 cites W2329648702 @default.
• W1966335217 doi "https://doi.org/10.1002/pbc.24121" @default.
• W1966335217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22378641" @default.
• W1966335217 hasPublicationYear "2012" @default.
• W1966335217 type Work @default.
• W1966335217 sameAs 1966335217 @default.
• W1966335217 citedByCount "48" @default.
• W1966335217 countsByYear W19663352172013 @default.
• W1966335217 countsByYear W19663352172014 @default.
• W1966335217 countsByYear W19663352172015 @default.
• W1966335217 countsByYear W19663352172016 @default.
• W1966335217 countsByYear W19663352172017 @default.
• W1966335217 countsByYear W19663352172018 @default.
• W1966335217 countsByYear W19663352172019 @default.
• W1966335217 countsByYear W19663352172020 @default.
• W1966335217 countsByYear W19663352172021 @default.
• W1966335217 countsByYear W19663352172022 @default.
• W1966335217 countsByYear W19663352172023 @default.
• W1966335217 crossrefType "journal-article" @default.
• W1966335217 hasAuthorship W1966335217A5016103334 @default.
• W1966335217 hasAuthorship W1966335217A5024930133 @default.
• W1966335217 hasAuthorship W1966335217A5032442321 @default.
• W1966335217 hasAuthorship W1966335217A5045437866 @default.
• W1966335217 hasAuthorship W1966335217A5070781431 @default.
• W1966335217 hasAuthorship W1966335217A5091260162 @default.
• W1966335217 hasConcept C126322002 @default.
• W1966335217 hasConcept C12868164 @default.
• W1966335217 hasConcept C141071460 @default.
• W1966335217 hasConcept C187212893 @default.
• W1966335217 hasConcept C206041023 @default.
• W1966335217 hasConcept C2776960273 @default.
• W1966335217 hasConcept C2777583451 @default.
• W1966335217 hasConcept C2778461978 @default.
• W1966335217 hasConcept C2778729363 @default.
• W1966335217 hasConcept C2780221984 @default.
• W1966335217 hasConcept C3019892230 @default.
• W1966335217 hasConcept C71924100 @default.
• W1966335217 hasConcept C72563966 @default.
• W1966335217 hasConcept C90924648 @default.
• W1966335217 hasConceptScore W1966335217C126322002 @default.
• W1966335217 hasConceptScore W1966335217C12868164 @default.
• W1966335217 hasConceptScore W1966335217C141071460 @default.
• W1966335217 hasConceptScore W1966335217C187212893 @default.
• W1966335217 hasConceptScore W1966335217C206041023 @default.
• W1966335217 hasConceptScore W1966335217C2776960273 @default.
• W1966335217 hasConceptScore W1966335217C2777583451 @default.
• W1966335217 hasConceptScore W1966335217C2778461978 @default.
• W1966335217 hasConceptScore W1966335217C2778729363 @default.
• W1966335217 hasConceptScore W1966335217C2780221984 @default.
• W1966335217 hasConceptScore W1966335217C3019892230 @default.
• W1966335217 hasConceptScore W1966335217C71924100 @default.
• W1966335217 hasConceptScore W1966335217C72563966 @default.
• W1966335217 hasConceptScore W1966335217C90924648 @default.
• W1966335217 hasIssue "5" @default.
• W1966335217 hasLocation W19663352171 @default.
• W1966335217 hasLocation W19663352172 @default.
• W1966335217 hasOpenAccess W1966335217 @default.
• W1966335217 hasPrimaryLocation W19663352171 @default.
• W1966335217 hasRelatedWork W1964663305 @default.
• W1966335217 hasRelatedWork W1979515567 @default.
• W1966335217 hasRelatedWork W2013094135 @default.
• W1966335217 hasRelatedWork W2082176708 @default.
• W1966335217 hasRelatedWork W2084739958 @default.
• W1966335217 hasRelatedWork W2094917937 @default.

• next